Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction

New England Journal of Medicine

Volumn 339, Issue 4, 1998, Pages 229-234

  Haffner, Steven M ^a   Lehto, Seppo ^b   Rönnemaa, Tapani ^c   Pyörälä, Kalevi ^b   Laakso, Markku ^b  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

^c Turku University   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; COMORBIDITY; CORONARY RISK; FEMALE; HEART INFARCTION; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RISK ASSESSMENT; SMOKING; SURVIVAL TIME;

CASE-CONTROL STUDIES; CORONARY DISEASE; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; FINLAND; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; SURVIVAL ANALYSIS;

EID: 0032560807     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199807233390404     Document Type: Article

References (25)

1. Kannel WB, McGee DL. Diabetes and glucose tolerance as risk factors for cardiovascular disease: the Framingham Study. Diabetes Care 1979;2: 120-6.
2. Wingard DL, Barrett -Connor E. Heart disease and diabetes. In: National Diabetes Data Group. Diabetes in America. 2nd ed. Washington, D.C.: Government Printing Office, 1995:429-48. (NIH publication no. 95-1468.)
3. Pyörälä K, Laakso M, Uusitupa M. Diabetes and atherosclerosis: an epidemiologic view. Diabetes Metab Rev 1987;3:463-524.
4. Stamler J, Vaccaro O, Neaton ID, Wentworth D. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 1993;16:434-44.
5. Pekkanen J, Linn S, Heiss G, et al. Ten-year mortality from cardiovascular disease in relation to cholesterol level among men with and without preexisting cardiovascular disease. N Engl J Med 1990;322:1700-7.
6. Rosengren A, Hagman M, Wedel H, Wilhelmsen L. Serum cholesterol and long-term prognosis in middle-aged men with myocardial infarction and angina pectoris: a 16-year follow-up of the Primary Prevention Study in Göteborg, Sweden. Eur Heart J 1997;18:754-61.
7. Rosengren A, Welin L, Tsipogianni A, Wilhelmsen L. Impact of cardiovascular risk factors on coronary heart disease and mortality among middle aged diabetic men: a general population study. BMJ 1989;299:1127-31.
8. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). JAMA 1993;209:3015-23.
9. American Diabetes Association. Management of dyslipidemia in adults with diabetes. Diabetes Care 1998;21:179-82.
10. Haffner SM. The Scandinavian Simvastatin Survival Study (4S) subgroup analysis of diabetic subjects: implications for the prevention of coronary heart disease. Diabetes Care 1997;20:469-71.
11. Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994;344:1383-9.
12. Pyörälä K, Pedersen TR, Kjekshus J, Faergeman O, Olsson AG, Thorgeirsson G. Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease: a subgroup analysis of the Scandinavian Simvastatin Survival Study (4S). Diabetes Care 1997;20:614-20. [Erratum, Diabetes Care 1997;20:1048.]
13. Sacks FM, Pfeffer MA, Moye LA, et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N Engl J Med 1996;335:1001-9.
14. Abbott RD, Donahue RP, Kannel WB, Wilson PW. The impact of diabetes on survival following myocardial infarction in men vs. women: the Framingham Study. JAMA 1988;260:3456-60. [Erratum, JAMA 1989; 261:1884.]
15. Herliz J, Karlson RW, Edvardsson N, Emanuelsson H, Hjalmarson Å. Prognosis in diabetics with chest pain or other symptoms suggestive of acute myocardial infarction. Cardiology 1992;80:237-45.
16. Miettinen H, Lehto S, Salomaa VV, et al. Impact of diabetes on mortality after the first myocardial infarction. Diabetes Care 1998;21:69-75.
17. Lehto S, Rönnemaa T, Haffner SM, Pyörälä K, Kallio V, Laakso M. Dyslipidemia and hyperglycemia predict coronary heart disease events in middle-aged patients with NIDDM. Diabetes 1997;46:1354-9.
18. Laakso M, Rönnemaa T, Pyörälä K, Kallio V, Puukka P, Penttilä I. Atherosclerotic vascular disease and its risk factors in non-insulin-dependent diabetic and nondiabetic subjects in Finland. Diabetes Care 1988;11:449-63.
19. Diabetes mellitus: report of a WHO study group. WHO Tech Rep Ser 1985;727:1-113.
20. Proposal for the multinational monitoring of trends and determinants in cardiovascular disease and protocol (MONICA Project). Geneva: World Health Organization, 1983. (Publication no. WHO/MNC/82.1 Rev.1.)
21. Walker AE, Robins M, Weinfeld FD. The National Survey of Stroke: clinical findings. Stroke 1981;12:Suppl I:1-13-1-44.
22. Cox DR. Regression models and life-tables. J R Stat Soc [B] 1972;34: 187-202.
23. Tunstall-Pedoe H, Kuulasmaa K, Amouyel P, Arveiler D, Rajakangas AM, Pajak A. Myocardial infarction and coronary deaths in the World Health Organization MONICA Project: registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents. Circulation 1994;90:583-612.
24. Laakso M, Rönnemaa T, Lehto S, Puukka P, Kallio V, Pyörälä K. Does NIDDM increase the risk for coronary heart disease similarly in both low- and high-risk populations? Diabetologia 1995;38:487-93.
25. D'Agostino RB Jr, Mykkänen L, Goff D, et al. Atherosclerosis in type 2 diabetic and non-diabetic subjects with and without previous myocardial infarction: the Insulin Resistance Atherosclerosis Study (IRAS). Presented at the American Heart Association 38th Annual Conference on Cardiovascular Disease: Epidemiology and Prevention, Santa Fe, N.M., March 18-21, 1998. abstract.